Lmr Partners LLP Vertex Pharmaceuticals Inc Transaction History

Lmr Partners LLP

$10.9 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $541,820 - $592,840	-1,329 Reduced 15.04%	7,509 $3.14 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $3.03 Million - $3.63 Million	8,838 New	8,838 $3.6 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $1.25 Million - $1.4 Million	-4,366 Reduced 23.0%	14,614 $4.22 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $1.35 Million - $1.51 Million	4,928 Added 35.07%	18,980 $5.5 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $2.67 Million - $3.33 Million	11,382 Added 426.29%	14,052 $3.96 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $9,742 - $11,482	-44 Reduced 1.62%	2,670 $697,000
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $11.7 Million - $14.8 Million	-66,116 Reduced 96.06%	2,714 $596,000
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $10.1 Million - $11.3 Million	-55,640 Reduced 44.7%	68,830 $12.5 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $22.5 Million - $26.6 Million	120,208 Added 2820.46%	124,470 $25.1 Million
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $2.43 Million - $2.83 Million	-11,727 Reduced 73.34%	4,262 $916,000
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $2.78 Million - $3.71 Million	13,447 Added 528.99%	15,989 $3.78 Million
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $10.6 Million - $12.6 Million	-41,532 Reduced 94.23%	2,542 $692,000
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $9.94 Million - $13 Million	44,074 New	44,074 $12.8 Million
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $2.49 Million - $3.09 Million	-12,477 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $1.28 Million - $1.72 Million	7,680 Added 160.1%	12,477 $2.73 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $418,567 - $471,092	2,518 Added 110.49%	4,797 $813,000
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $375,146 - $433,853	2,279 New	2,279 $418,000
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $567,651 - $675,024	-3,467 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $526,671 - $666,392	3,467 New	3,467 $575,000
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $458,909 - $527,336	-2,736 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$145.72 - $169.96 $1.15 Million - $1.34 Million	-7,896 Reduced 74.27%	2,736 $465,000
Q4 2017 Jan 30, 2018	BUY	$137.28 - $155.55 $726,485 - $823,170	5,292 Added 99.1%	10,632 $1.59 Million
Q3 2017 Nov 09, 2017	BUY	$148.13 - $162.24 $791,014 - $866,361	5,340	5,340 $812,000

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.1 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.4 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.61 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.33 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.06 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Account